MINERVAX ApS: Financial statements 2013
CVR: 32673287
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
MINERVAX ApS (CVR 32673287) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 4,568,982 and a net result of DKK -2,146,519 compared with DKK -845,708 the year before. The profit margin was -47%. Equity in the 2013 report amounted to DKK -719,299.
- Revenue
- DKK 4,568,982
- Gross Profit
- DKK -2,569,386
- Profit/Loss
- DKK -2,146,519
- Equity
- DKK -719,299
- Total Assets
- DKK 7,133,315
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | 4.6 mio. | -2.6 mio. | -2.1 mio. | -719 t. | - |
| 2012 | - | -1.1 mio. | -846 t. | 1.4 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of December 4, 2013, Lars Thomas Joakim Areschoug has left the board of directors of MINERVAX ApS.
As of October 1, 2013, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of MINERVAX ApS.
As of October 1, 2013, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of MINERVAX ApS.
As of September 27, 2013, Ingelise Saunders has joined the board of directors of MINERVAX ApS.
As of September 27, 2013, Steen Søren Klysner has left the board of directors of MINERVAX ApS.
MINERVAX ApS has published its annual report for 2012. Gross profit came to DKK -1,060,392, and the net result was DKK -845,708.
As of April 5, 2013, Line Holten Reimer has joined the board of directors of MINERVAX ApS.
As of April 5, 2013, Ole Bitsch-Jensen has left the board of directors of MINERVAX ApS.
About MINERVAX ApS
MINERVAX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Veronica Gambillara Fonck (chair), Bita Sehat, Christopher J. Gagliardi and Emmanuelle Coutanceau. The company's owners include Novo Holdings A/S, SUNSTONE LIFE SCIENCE VENTURES FUND III K/S and Wellington Partners Life Sciences V GmbH & Co. KG. The company has 2 employees (2018). In 2025, the company reported a net result of EUR -31,530,000 compared with EUR -29,126,000 the year before. Equity in the 2025 report amounted to EUR 9,787,000.